Profile
Full Name
Galectin Therapeutics Inc.Ticker Symbol
GALTExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
September 4, 2002Indexes
Not includedEmployees
15Key Details
Price
$1.35(+0.75%)
Market cap
$85.29M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$0.76(-2.70% YoY)
PE ratio
-
Next earnings date
May 15, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Galectin Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 2, 25 HC Wainwright & Co.
NeutralDec 27, 24 HC Wainwright & Co.
NeutralNov 15, 24 HC Wainwright & Co.
BuyAug 16, 24 HC Wainwright & Co.
BuyApr 9, 24 HC Wainwright & Co.
BuyApr 1, 24 HC Wainwright & Co.
BuyAug 15, 23 HC Wainwright & Co.
BuyMay 17, 23 HC Wainwright & Co.
BuyMar 3, 23 HC Wainwright & Co.
BuyMay 17, 22 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Galectin Therapeutics?
- Does Galectin Therapeutics pay dividends?
- What sector is Galectin Therapeutics in?
- What industry is Galectin Therapeutics in?
- What country is Galectin Therapeutics based in?
- When did Galectin Therapeutics go public?
- Is Galectin Therapeutics in the S&P 500?
- Is Galectin Therapeutics in the NASDAQ 100?
- Is Galectin Therapeutics in the Dow Jones?
- When was Galectin Therapeutics's last earnings report?
- When does Galectin Therapeutics report earnings?
- Should I buy Galectin Therapeutics stock now?
What is the ticker symbol for Galectin Therapeutics?
The ticker symbol for Galectin Therapeutics is NASDAQ:GALT
Does Galectin Therapeutics pay dividends?
No, Galectin Therapeutics does not pay dividends
What sector is Galectin Therapeutics in?
Galectin Therapeutics is in the Healthcare sector
What industry is Galectin Therapeutics in?
Galectin Therapeutics is in the Biotechnology industry
What country is Galectin Therapeutics based in?
Galectin Therapeutics is headquartered in United States
When did Galectin Therapeutics go public?
Galectin Therapeutics's initial public offering (IPO) was on September 4, 2002
Is Galectin Therapeutics in the S&P 500?
No, Galectin Therapeutics is not included in the S&P 500 index
Is Galectin Therapeutics in the NASDAQ 100?
No, Galectin Therapeutics is not included in the NASDAQ 100 index
Is Galectin Therapeutics in the Dow Jones?
No, Galectin Therapeutics is not included in the Dow Jones index
When was Galectin Therapeutics's last earnings report?
Galectin Therapeutics's most recent earnings report was on Mar 31, 2025
When does Galectin Therapeutics report earnings?
The next expected earnings date for Galectin Therapeutics is May 15, 2025
Should I buy Galectin Therapeutics stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions